Targeting glycosylation to sensitize breast cancer cells to immune therapy (make immunologically “cold tumors” into immunologically recognizable “hot tumors”). Thanks to @smereiter.bsky.social, the whole team and the T. Von Zastrow Foundation!
🚨 Our newest manuscript is out in Nature Communications: Hypersialylation in breast cancer immunoregulation: uncovering novel mechanisms and highlighting major therapeutic potential. +6 years in the making. Dive into: tinyurl.com/sialic @meduniwien.ac.at